Logynon Tablets
Authorisation PA1410/005/001 · Bayer Limited
- Licence holder
- Bayer Limited (all products →)
- Active substances
- Levonorgestrel, Levonorgestrel, Levonorgestrel, Ethinylestradiol, Ethinylestradiol, Ethinylestradiol
- Clinical trials
- 3 clinical trials → 3 clinical trials → 3 clinical trials →
- Dosage form
- Coated tablet
- Route of administration
- Oral use
- ATC codes
- G03AB, G03AB03
- First authorised
- 26/08/1981
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Levonorgestrel: supply and approvals
26 authorised products on the HPRA list contain Levonorgestrel. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 18 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 18 Nov 2026)
- Germany (BfArM)
- 2 supply notices, e.g. Levosert 20 Mikrogramm/24 Stunden intrauterines Wirkstofffreisetzungssystem (22 Jun 2026 to 31 Dec 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 45 years (since 26 August 1981). The HPRA list marks it as marketed in Ireland.
Other medicines with Levonorgestrel in Ireland
23 other products on the HPRA list contain Levonorgestrel, from 9 licence holders; 10 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Jaydess 13.5 mg intrauterine delivery system | Bayer Limited | National authorisation (PA) | Marketed |
| Kyleena 19.5 mg intrauterine delivery system | Bayer Limited | National authorisation (PA) | Marketed |
| Leonore 100 micrograms/20 micrograms coated tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Levonorgestrel Rowex 1.5mg Tablet | Rowex Limited, | National authorisation (PA) | Marketed |
| Microlite 100 microgram/20 microgram coated tablets | Bayer Limited | National authorisation (PA) | Marketed |
| Mirena 52 mg intrauterine delivery system | Bayer Limited | National authorisation (PA) | Marketed |
| Ovranette 150 micrograms/30 micrograms coated tablets | Pfizer Healthcare Ireland Unlimited Company | National authorisation (PA) | Marketed |
| Ovreena 30 micrograms/150 micrograms coated tablets | Gedeon Richter Plc | National authorisation (PA) | Marketed |
| Ramonna 1500 microgram Tablet | Gedeon Richter Plc | National authorisation (PA) | Marketed |
| Violite 100/20 micrograms film-coated tablets | Gedeon Richter Plc | National authorisation (PA) | Marketed |
| Kyleena 19.5 mg intrauterine delivery system | IMED Healthcare Ltd., | Parallel import (PPA) | Not stated |
| Kyleena 19.5 mg intrauterine delivery system | PCO Manufacturing Ltd. | Parallel import (PPA) | Not stated |
Other medicines with Levonorgestrel in Ireland
23 other products on the HPRA list contain Levonorgestrel, from 9 licence holders; 10 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Jaydess 13.5 mg intrauterine delivery system | Bayer Limited | National authorisation (PA) | Marketed |
| Kyleena 19.5 mg intrauterine delivery system | Bayer Limited | National authorisation (PA) | Marketed |
| Leonore 100 micrograms/20 micrograms coated tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Levonorgestrel Rowex 1.5mg Tablet | Rowex Limited, | National authorisation (PA) | Marketed |
| Microlite 100 microgram/20 microgram coated tablets | Bayer Limited | National authorisation (PA) | Marketed |
| Mirena 52 mg intrauterine delivery system | Bayer Limited | National authorisation (PA) | Marketed |
| Ovranette 150 micrograms/30 micrograms coated tablets | Pfizer Healthcare Ireland Unlimited Company | National authorisation (PA) | Marketed |
| Ovreena 30 micrograms/150 micrograms coated tablets | Gedeon Richter Plc | National authorisation (PA) | Marketed |
| Ramonna 1500 microgram Tablet | Gedeon Richter Plc | National authorisation (PA) | Marketed |
| Violite 100/20 micrograms film-coated tablets | Gedeon Richter Plc | National authorisation (PA) | Marketed |
| Kyleena 19.5 mg intrauterine delivery system | IMED Healthcare Ltd., | Parallel import (PPA) | Not stated |
| Kyleena 19.5 mg intrauterine delivery system | PCO Manufacturing Ltd. | Parallel import (PPA) | Not stated |
Other substances in ATC group G03AB
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 1 other active substance shares the group G03AB with this product:
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Bayer Limited holds 53 products on the HPRA list, with 38 different active substances; 32 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 19 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.